« All News & Opportunities

20th July 2022

Funding Call: DASA have opened four themed competitions

DASA currently have four themed competitions open (three of which are brand new) –

The Veterans Health Care Innovation Fund – DASA have £2.7m of funding available on behalf of the Office of Veterans Affairs to look at innovations that improve the techniques and pathways for meeting veterans’ physical and mental health needs. This competition is slightly different from previous as there are specific Terms and Conditions for applications from academia, charities and Public Sector research institutions. Closing Date of 31 August at midday

Generation after next Wearable Technologies – up to £750k of funding available for innovative wearable technologies that focus on wearable biocompatible technologies and innovations that move beyond the measurement of physical parameters such as heart rate, and instead, towards the capability to measure data present in the individual’s body fluids, such as blood, sweat, tears, saliva and tissue fluids. Closing Date of 25 August at midday.

Engineering Biology for Defence and Security – this competition seeks proposals for innovative technologies that take synthetic biology concepts, and uses them to improve defence capability and address its challenges. This call involved the US Department of Defense (DoD) and specifically seeks innovation within synthetic biology across; power and energy technologies, materials for Defence and Sensing. Competition closes on 26 August at midday.

Its good for Missiles to talk – we are aiming to identify and develop novel technologies that could be exploited in the development of a new category of missile – cooperative missiles. It is envisioned that by working together, cooperative missiles will offer the UK armed forces far more capability in the future than they have today. This includes technologies around distributed detection, identification, navigation, data processing and Artificial Intelligence. Competition closes on 02 August 2022 at midday.